Investor Presentation H1 2023

122 Investor presentation First six months of 2023 GLP-1 market share and market growth in EMEA 80% 60% 40% 20% GLP-1 market growth and Novo Nordisk market share 0% May 2020 NN market share -Market growth (right axis) GLP-1 market size and growth DKK billion 80% -38% 3 69% 6 62% 60% 44% 38% 40% 21 21 20% 59% EMEA 29 ~44% 62% 0% May May May Novo Nordisk Company A Others 2023 2022 2023 Novo Nordisk Competitors -NN share of growth -NN growth (right axis) Source: IQVIA, May 2023, Value, MAT; Due to contractual obligations competitor names are not disclosed. Company A represents an actual company. EMEA: Europe, Middle East and Africa; NN: Novo Nordisk

View entire presentation